Myriad Genetics · 9 hours ago
Sr Computational Scientist
United States
Full-time
Remote
Mid, Senior Level
4+ years expMyriad Genetics is a leading company in the biotechnology sector, seeking a Senior Computational Scientist to work at the interface of product development and evidence generation. The role involves analyzing data from research studies, authoring scientific manuscripts, and collaborating with clinical and biopharma teams to enhance product development and clinical applications.
BiotechnologyPharmaceuticalPrecision Medicine
No H1B
U.S. Citizen Only
Responsibilities
Analyze data from research and clinical studies, present results to internal stakeholders and to external partners, and ensure successful completion of the studies
Author and review scientific manuscripts, abstracts, and conference presentations to communicate key findings and innovations from Myriad’s research efforts, often in direct collaboration with partners in academia, pharma, and community medicine
Partner with clinical development and biopharma teams to initiate MRD partnerships and prioritize opportunities for the business
Distill learnings from research and clinical data to identify areas of improvement in our assays, and as appropriate, actively implement those improvements
Mentor junior scientists and research associates, guiding the overall path and success of key projects
Use expertise in genomics and oncology to help guide Myriad’s strategy for MRD product development and clinical applications
Qualification
Required
PhD with 4+ years of industry experience in applying genomic technologies for clinical applications or product development
Strong computational skills in Python or R for data analysis and presentation
Track record of scientific communication, such as through peer-reviewed publications and presenting at national conferences
Experience developing analysis methods, algorithms, and pipelines, particularly with next generation sequencing (NGS) data
Working knowledge of nucleic acid chemistry and genetics
Applicant must be a (i) U.S. citizen or national, (ii) U.S. lawful, permanent resident (aka green card holder)
Preferred
Preferred experience in R&D with non-invasive technologies, oncology, and regulated clinical diagnostic products (CLIA, FDA)
Company
Myriad Genetics
Myriad Genetics discovers, develops, and commercializing novel therapies for the treatment of cancer.
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$215MKey Investors
OrbiMed
2025-07-31Post Ipo Debt· $125M
2023-07-06Post Ipo Debt· $90M
1995-10-13IPO
Leadership Team
Sam Raha
CEO | President | Board member
Ben Wheeler
Chief Financial Officer
Recent News
Company data provided by crunchbase